000	00000nam 2200000zi 4500
001	9.891374
003	CaOODSP
005	20221107172850
006	m     o  d f
007	cr |||||||||||
008	200910e202010##onca    ob   f000 0 eng d
020	|a9780660360126
040	|aCaOODSP|beng|erda|cCaOODSP
043	|an-cn---
086	1 |aHP40-274/2020E-PDF
245	00|aPreliminary guidance on key populations for early COVID-19 immunization.
246	1 |iAt head of title : |aAn Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)
264	1|aOttawa, ON : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |cOctober 2020.
264	4|c©2020
300	|a1 online resource (49 pages) : |billustrations
336	|atext|btxt|2rdacontent
337	|acomputer|bc|2rdamedia
338	|aonline resource|bcr|2rdacarrier
500	|aIssued also in French under title: Orientations préliminaires sur les principales populations à immuniser en priorité contre la COVID-19.
500	|aIssued also in HTML format.
504	|aIncludes bibliographical references (pages 31-33).
520	|a"The objective of this advisory committee statement is to provide preliminary guidance for public health program level decision-making to plan for the efficient, effective, and equitable allocation of a novel coronavirus disease 2019 (COVID-19) vaccine once it is authorized for use in Canada when limited initial vaccine supply will necessitate the prioritization of immunization in some populations earlier than others"--Page 5.
650	0|aCOVID-19 (Disease)|xVaccination|zCanada.
650	0|aCOVID-19 (Disease)|xVaccination|xGovernment policy|zCanada.
710	2 |aPublic Health Agency of Canada, |eissuing body.
775	08|tOrientations préliminaires sur les principales populations à immuniser en priorité contre la COVID-19.|w(CaOODSP)9.891373
856	40|qPDF|s1.90 MB|uhttps://publications.gc.ca/collections/collection_2021/aspc-phac/HP40-274-2020-eng.pdf
856	4 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/guidance-key-populations-early-covid-19-immunization.html
986	|aPub.: 200191